Methods and compositions for prolonging elimination half-times of bioactive compounds

Details for Australian Patent Application No. 2009201933 (hide)

Owner Genentech, Inc.

Inventors Dennis, Mark S.; Lowman, Henry B.; Delano, Warren L.

Agent Griffith Hack

Pub. Number AU-A-2009201933

Parent 2006202341

Filing date 15 May 2009

Wipo publication date 4 June 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

4 June 2009 Application Open to Public Inspection

  Published as AU-A-2009201933

4 June 2009 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201934-Adjustable Door Support Rollers

2009201932-Detection of CD20 in therapy of autoimmune diseases